Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli ...
Duet, a network of nurse practitioner-owned primary care practices, announced on Thursday that it raised $15 million in ...
We are investing billions in making cancer treatment more precise while too many patients still can’t reliably reach the ...
Servier’s sevasemten came from the acquisition of the muscular dystrophy assets of Edgewise Therapeutics. While the small ...
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...
Typically, software placed on the market will undergo changes and updates after its initial release. In the case of ...
The Series B round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures, ...
The question facing healthcare leaders today is no longer whether Artificial Intelligence (AI) will be transformative, but whether our organizations can transform quickly enough to harness it at an ...
When governments fall short on public health, hospitals inherit the fallout. Those with the strongest brands are best positioned to withstand it.
Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera's ...
Now the MSSP has had success — it saved more than $2.1 billion in 2023, the largest savings in its history — but it’s just ...